Guoshun Luo

1.1k total citations
46 papers, 858 citations indexed

About

Guoshun Luo is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Guoshun Luo has authored 46 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Genetics and 15 papers in Organic Chemistry. Recurrent topics in Guoshun Luo's work include Estrogen and related hormone effects (19 papers), Synthesis and biological activity (9 papers) and Protein Degradation and Inhibitors (9 papers). Guoshun Luo is often cited by papers focused on Estrogen and related hormone effects (19 papers), Synthesis and biological activity (9 papers) and Protein Degradation and Inhibitors (9 papers). Guoshun Luo collaborates with scholars based in China, United States and Switzerland. Guoshun Luo's co-authors include Hua Xiang, Xin Lin, Xiang Lu, Qidong You, Xinyu Li, Hanlin Wei, Linyi Liu, Zhichao Tang, Shengnan Ren and Michael J. Krische and has published in prestigious journals such as ACS Nano, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Guoshun Luo

43 papers receiving 851 citations

Peers

Guoshun Luo
Rachel E. Davis United States
Hank La United States
André Richters Germany
Liang Xiong China
Renaud Prudent France
Lan-Zhen Wang United Kingdom
Kanami Yamazaki Japan
Keith R. Hornberger United States
Bernard Barlaam United Kingdom
Radek Jorda Czechia
Rachel E. Davis United States
Guoshun Luo
Citations per year, relative to Guoshun Luo Guoshun Luo (= 1×) peers Rachel E. Davis

Countries citing papers authored by Guoshun Luo

Since Specialization
Citations

This map shows the geographic impact of Guoshun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoshun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoshun Luo more than expected).

Fields of papers citing papers by Guoshun Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoshun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoshun Luo. The network helps show where Guoshun Luo may publish in the future.

Co-authorship network of co-authors of Guoshun Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Guoshun Luo. A scholar is included among the top collaborators of Guoshun Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoshun Luo. Guoshun Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Guoshun, et al.. (2026). A patent review of DNA polymerase theta (Polθ) targeted therapies (2019–2025). Expert Opinion on Therapeutic Patents. 36(3). 235–260.
2.
Luo, Guoshun, et al.. (2026). Approved Steroidal Drugs (2000–2025): A Medicinal Chemistry Perspective. Journal of Medicinal Chemistry. 69(2). 765–791.
3.
Xiang, Hua, et al.. (2025). Targeted degradation of Werner syndrome helicase (WRN) via ligand-directed covalent hydrophobic tagging. European Journal of Medicinal Chemistry. 300. 118121–118121.
4.
Ji, Changwei, et al.. (2024). Discovery of a highly potent, N-terminal domain-targeting degrader of AR-FL/AR-V7 for the treatment of prostate cancer. European Journal of Medicinal Chemistry. 282. 117079–117079. 1 indexed citations
5.
Wang, Xin, Ke Song, Xinyan Liu, et al.. (2023). Structural optimization of tetrahydroisoquinoline-hydroxamate hybrids as potent dual ERα degraders and HDAC inhibitors. Bioorganic Chemistry. 134. 106459–106459. 9 indexed citations
6.
Chen, Xing, et al.. (2023). Precisely Amplifying Intracellular Oxidative Storm by Metal–Organic Coordination Polymers to Augment Anticancer Immunity. ACS Nano. 17(15). 15165–15179. 13 indexed citations
7.
Wu, Shuangjie, Lin Qi, Mingqi Chen, et al.. (2022). Novel 6-amino-1,3,5-triazine derivatives as potent BTK inhibitors: structure-activity relationship (SAR) analysis and preliminary mechanism investigation. Bioorganic Chemistry. 130. 106263–106263. 7 indexed citations
8.
Luo, Guoshun, et al.. (2022). Novel 11β-substituted estradiol conjugates: Transition from ERα agonizts to effective PROTAC degraders. The Journal of Steroid Biochemistry and Molecular Biology. 223. 106154–106154. 4 indexed citations
9.
Ren, Shengnan, et al.. (2021). Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer. European Journal of Medicinal Chemistry. 221. 113543–113543. 13 indexed citations
10.
Luo, Guoshun, Xin Lin, Shengnan Ren, et al.. (2021). Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer. European Journal of Medicinal Chemistry. 226. 113870–113870. 17 indexed citations
11.
Wu, Shuangjie, et al.. (2021). Benzothiophene derivatives as selective estrogen receptor covalent antagonists: Design, synthesis and anti-ERα activities. Bioorganic & Medicinal Chemistry. 47. 116395–116395. 12 indexed citations
12.
13.
14.
Luo, Guoshun, et al.. (2020). Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator. European Journal of Medicinal Chemistry. 209. 112910–112910. 8 indexed citations
15.
Lin, Xin, et al.. (2020). Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer. Bioorganic & Medicinal Chemistry. 28(23). 115763–115763. 15 indexed citations
16.
Lin, Xin, Xiang Lu, Guoshun Luo, & Hua Xiang. (2019). Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules. European Journal of Medicinal Chemistry. 186. 111876–111876. 121 indexed citations
17.
Luo, Guoshun, Linyi Liu, Mingqi Chen, et al.. (2018). Structure-guided design and synthesis of isoflavone analogs of GW4064 with potent lipid accumulation inhibitory activities. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3726–3730. 13 indexed citations
18.
Luo, Guoshun, Xinyu Li, Fan Zheng, et al.. (2018). Lipid accumulation inhibitory activities of novel isoxazole-based chenodeoxycholic acids: Design, synthesis and preliminary mechanism study. Bioorganic & Medicinal Chemistry Letters. 28(17). 2879–2884. 11 indexed citations
19.
Luo, Guoshun, et al.. (2018). Structure-activity relationships of 2, 4-disubstituted pyrimidines as dual ERα/VEGFR-2 ligands with anti-breast cancer activity. European Journal of Medicinal Chemistry. 150. 783–795. 37 indexed citations
20.
Liu, Linyi, Bingyu Shi, Xinyu Li, et al.. (2018). Design and synthesis of benzofuro[3,2-b]pyridin-2(1H)-one derivatives as anti-leukemia agents by inhibiting Btk and PI3Kδ. Bioorganic & Medicinal Chemistry. 26(15). 4537–4543. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel E. Davis Breakdown of academic impact, for papers by Hank La Breakdown of academic impact, for papers by André Richters Breakdown of academic impact, for papers by Liang Xiong Breakdown of academic impact, for papers by Renaud Prudent Breakdown of academic impact, for papers by Lan-Zhen Wang Breakdown of academic impact, for papers by Kanami Yamazaki Breakdown of academic impact, for papers by Keith R. Hornberger Breakdown of academic impact, for papers by Bernard Barlaam Breakdown of academic impact, for papers by Radek Jorda
Rankless by CCL
2026